Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kite Pharma

Founders Arie Belldegrun Joshua Kazam

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$71M
Portfolio companies 10
Rounds per year 1.00
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
Summary

Kite Pharma is the famous Corporate Investor, which was founded in 2009. The main office of represented Corporate Investor is situated in the Los Angeles. The company was established in North America in United States.

Deals in the range of 50 - 100 millions dollars are the general things for fund. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2017.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Kite Pharma, startups are often financed by Nest.Bio Ventures, Viventures, Utrecht Holdings. The meaningful sponsors for the fund in investment in the same round are VI Ventures, Two River, Sequoia Capital China.

Among the most popular fund investment industries, there are Health Care, Medical. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight HiFiBiO, Gadeta, Cell Design Labs. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

This organization was formed by Arie Belldegrun, Joshua A. Kazam.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kite Pharma:
Typical Co-investors
Kite Pharma is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kite Pharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CHC Capital Beijing, Beijing Shi, China
Grey Sky Venture Partners -
Inseed Investimentos Belo Horizonte, Brazil, Minas Gerais
Jane Street Capital New York, New York, United States
Meritz Real Estate Asset Management Seoul, Seoul-t'ukpyolsi, South Korea
NBCi California, San Francisco, United States
NextProtocol Ventures -
Norwich Ventures Cambridge, Massachusetts, United States
Silver Point Capital, L.P. Connecticut, Greenwich, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Ensoma

Biotechnology
Genetics
Therapeutics
$50M16 May 2023 Boston, Massachusetts, United States

Shoreline Biosciences

Biotechnology
Life Science
Medical
$140M02 Nov 2021 San Diego, California, United States

Biotechnology
Medical
Pharmaceutical
Therapeutics
$80M24 Feb 2021 Cambridge, Massachusetts, United States

Shoreline Biosciences

Biotechnology
Life Science
Medical
$43M07 Feb 2021 San Diego, California, United States

Vineti

Biotechnology
Cloud Computing
Enterprise Software
Software
Therapeutics
$35M05 Feb 2020 San Francisco, California, United States

HiFiBiO

Biopharma
Biotechnology
Pharmaceutical
Therapeutics
$67M28 Aug 2019 Paris, Ile-de-France, France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kite Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 15
Average round size 71M
Rounds per year 1.00
Peak activity year 2021
Lead investments 1
Follow on index 0.33
Exits 2
Group Appearance index 0.73

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Ensoma

Biotechnology
Genetics
Therapeutics
$50M16 May 2023 Boston, Massachusetts, United States

Shoreline Biosciences

Biotechnology
Life Science
Medical
$140M02 Nov 2021 San Diego, California, United States

Biotechnology
Medical
Pharmaceutical
Therapeutics
$80M24 Feb 2021 Cambridge, Massachusetts, United States

Shoreline Biosciences

Biotechnology
Life Science
Medical
$43M07 Feb 2021 San Diego, California, United States

Vineti

Biotechnology
Cloud Computing
Enterprise Software
Software
Therapeutics
$35M05 Feb 2020 San Francisco, California, United States

HiFiBiO

Biopharma
Biotechnology
Pharmaceutical
Therapeutics
$67M28 Aug 2019 Paris, Ile-de-France, France
Crunchbase icon

Content report

The following text will be sent to our editors: